minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.1.0 - STU 2.1
minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.1.0 - STU 2.1
This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.1.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions 
| Active as of 2023-03-21 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="elixhauser-coagulation-deficiency-vs"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://terminology.hl7.org/5.0.0/CodeSystem-icd10CM.html"><code>http://hl7.org/fhir/sid/icd-10-cm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>D61.09</td><td>Other constitutional aplastic anemia</td></tr><tr><td>D61.1</td><td>Drug-induced aplastic anemia</td></tr><tr><td>D61.2</td><td>Aplastic anemia due to other external agents</td></tr><tr><td>D61.3</td><td>Idiopathic aplastic anemia</td></tr><tr><td>D61.810</td><td>Antineoplastic chemotherapy induced pancytopenia</td></tr><tr><td>D61.811</td><td>Other drug-induced pancytopenia</td></tr><tr><td>D61.818</td><td>Other pancytopenia</td></tr><tr><td>D61.82</td><td>Myelophthisis</td></tr><tr><td>D61.89</td><td>Oth aplastic anemias and other bone marrow failure syndromes</td></tr><tr><td>D61.9</td><td>Aplastic anemia, unspecified</td></tr><tr><td>D65</td><td>Disseminated intravascular coagulation</td></tr><tr><td>D66</td><td>Hereditary factor VIII deficiency</td></tr><tr><td>D67</td><td>Hereditary factor IX deficiency</td></tr><tr><td>D68.0</td><td>Von Willebrand's disease</td></tr><tr><td>D68.1</td><td>Hereditary factor XI deficiency</td></tr><tr><td>D68.2</td><td>Hereditary deficiency of other clotting factors</td></tr><tr><td>D68.311</td><td>Acquired hemophilia</td></tr><tr><td>D68.312</td><td>Antiphospholipid antibody with hemorrhagic disorder</td></tr><tr><td>D68.318</td><td>Oth hemorrhagic disord d/t intrns circ anticoag,antib,inhib</td></tr><tr><td>D68.32</td><td>Hemorrhagic disord d/t extrinsic circulating anticoagulants</td></tr><tr><td>D68.4</td><td>Acquired coagulation factor deficiency</td></tr><tr><td>D68.8</td><td>Other specified coagulation defects</td></tr><tr><td>D68.9</td><td>Coagulation defect, unspecified</td></tr><tr><td>D69.1</td><td>Qualitative platelet defects</td></tr><tr><td>D69.3</td><td>Immune thrombocytopenic purpura</td></tr><tr><td>D69.41</td><td>Evans syndrome</td></tr><tr><td>D69.42</td><td>Congenital and hereditary thrombocytopenia purpura</td></tr><tr><td>D69.49</td><td>Other primary thrombocytopenia</td></tr><tr><td>D69.51</td><td>Posttransfusion purpura</td></tr><tr><td>D69.59</td><td>Other secondary thrombocytopenia</td></tr><tr><td>D69.6</td><td>Thrombocytopenia, unspecified</td></tr><tr><td>D69.8</td><td>Other specified hemorrhagic conditions</td></tr><tr><td>D69.9</td><td>Hemorrhagic condition, unspecified</td></tr><tr><td>D75.82</td><td>Heparin induced thrombocytopenia (HIT)</td></tr><tr><td>O99.111</td><td>Oth dis of bld/bld-form org/immun mechnsm comp preg, 1st tri</td></tr><tr><td>O99.112</td><td>Oth dis of bld/bld-form org/immun mechnsm comp preg, 2nd tri</td></tr><tr><td>O99.113</td><td>Oth dis of bld/bld-form org/immun mechnsm comp preg, 3rd tri</td></tr><tr><td>O99.119</td><td>Oth dis of bld/bld-form org/immun mechnsm comp preg,unsp tri</td></tr><tr><td>O99.12</td><td>Oth dis of the bld/bld-form org/immun mechnsm comp chldbrth</td></tr><tr><td>O99.13</td><td>Oth dis of the bld/bld-form org/immun mechnsm comp the puerp</td></tr></table></li></ul></div>
</text>
<url
value="http://hl7.org/fhir/us/mcode/ValueSet/elixhauser-coagulation-deficiency-vs"/>
<version value="2.1.0"/>
<name value="ElixhauserCoagulationDeficiencyVS"/>
<title value="Elixhauser Coagulation Deficiency Value Set"/>
<status value="active"/>
<experimental value="false"/>
<date value="2023-03-21T04:50:14+11:00"/>
<publisher value="HL7 International Clinical Interoperability Council"/>
<contact>
<name value="HL7 International Clinical Interoperability Council"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/cic"/>
</telecom>
<telecom>
<system value="email"/>
<value value="ciclist@lists.HL7.org"/>
</telecom>
</contact>
<description
value="Elixhauser Comorbid Condition Value Set for Coagulation Deficiency. ICD-10 codes are drawn from https://www.hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/comorbidity_icd10.jsp, version 2021.1"/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="US"/>
<display value="United States of America"/>
</coding>
</jurisdiction>
<compose>
<include>
<system value="http://hl7.org/fhir/sid/icd-10-cm"/>
<concept>
<code value="D61.09"/>
<display value="Other constitutional aplastic anemia"/>
</concept>
<concept>
<code value="D61.1"/>
<display value="Drug-induced aplastic anemia"/>
</concept>
<concept>
<code value="D61.2"/>
<display value="Aplastic anemia due to other external agents"/>
</concept>
<concept>
<code value="D61.3"/>
<display value="Idiopathic aplastic anemia"/>
</concept>
<concept>
<code value="D61.810"/>
<display value="Antineoplastic chemotherapy induced pancytopenia"/>
</concept>
<concept>
<code value="D61.811"/>
<display value="Other drug-induced pancytopenia"/>
</concept>
<concept>
<code value="D61.818"/>
<display value="Other pancytopenia"/>
</concept>
<concept>
<code value="D61.82"/>
<display value="Myelophthisis"/>
</concept>
<concept>
<code value="D61.89"/>
<display
value="Oth aplastic anemias and other bone marrow failure syndromes"/>
</concept>
<concept>
<code value="D61.9"/>
<display value="Aplastic anemia, unspecified"/>
</concept>
<concept>
<code value="D65"/>
<display value="Disseminated intravascular coagulation"/>
</concept>
<concept>
<code value="D66"/>
<display value="Hereditary factor VIII deficiency"/>
</concept>
<concept>
<code value="D67"/>
<display value="Hereditary factor IX deficiency"/>
</concept>
<concept>
<code value="D68.0"/>
<display value="Von Willebrand's disease"/>
</concept>
<concept>
<code value="D68.1"/>
<display value="Hereditary factor XI deficiency"/>
</concept>
<concept>
<code value="D68.2"/>
<display value="Hereditary deficiency of other clotting factors"/>
</concept>
<concept>
<code value="D68.311"/>
<display value="Acquired hemophilia"/>
</concept>
<concept>
<code value="D68.312"/>
<display value="Antiphospholipid antibody with hemorrhagic disorder"/>
</concept>
<concept>
<code value="D68.318"/>
<display
value="Oth hemorrhagic disord d/t intrns circ anticoag,antib,inhib"/>
</concept>
<concept>
<code value="D68.32"/>
<display
value="Hemorrhagic disord d/t extrinsic circulating anticoagulants"/>
</concept>
<concept>
<code value="D68.4"/>
<display value="Acquired coagulation factor deficiency"/>
</concept>
<concept>
<code value="D68.8"/>
<display value="Other specified coagulation defects"/>
</concept>
<concept>
<code value="D68.9"/>
<display value="Coagulation defect, unspecified"/>
</concept>
<concept>
<code value="D69.1"/>
<display value="Qualitative platelet defects"/>
</concept>
<concept>
<code value="D69.3"/>
<display value="Immune thrombocytopenic purpura"/>
</concept>
<concept>
<code value="D69.41"/>
<display value="Evans syndrome"/>
</concept>
<concept>
<code value="D69.42"/>
<display value="Congenital and hereditary thrombocytopenia purpura"/>
</concept>
<concept>
<code value="D69.49"/>
<display value="Other primary thrombocytopenia"/>
</concept>
<concept>
<code value="D69.51"/>
<display value="Posttransfusion purpura"/>
</concept>
<concept>
<code value="D69.59"/>
<display value="Other secondary thrombocytopenia"/>
</concept>
<concept>
<code value="D69.6"/>
<display value="Thrombocytopenia, unspecified"/>
</concept>
<concept>
<code value="D69.8"/>
<display value="Other specified hemorrhagic conditions"/>
</concept>
<concept>
<code value="D69.9"/>
<display value="Hemorrhagic condition, unspecified"/>
</concept>
<concept>
<code value="D75.82"/>
<display value="Heparin induced thrombocytopenia (HIT)"/>
</concept>
<concept>
<code value="O99.111"/>
<display
value="Oth dis of bld/bld-form org/immun mechnsm comp preg, 1st tri"/>
</concept>
<concept>
<code value="O99.112"/>
<display
value="Oth dis of bld/bld-form org/immun mechnsm comp preg, 2nd tri"/>
</concept>
<concept>
<code value="O99.113"/>
<display
value="Oth dis of bld/bld-form org/immun mechnsm comp preg, 3rd tri"/>
</concept>
<concept>
<code value="O99.119"/>
<display
value="Oth dis of bld/bld-form org/immun mechnsm comp preg,unsp tri"/>
</concept>
<concept>
<code value="O99.12"/>
<display
value="Oth dis of the bld/bld-form org/immun mechnsm comp chldbrth"/>
</concept>
<concept>
<code value="O99.13"/>
<display
value="Oth dis of the bld/bld-form org/immun mechnsm comp the puerp"/>
</concept>
</include>
</compose>
</ValueSet>
IG © 2022+ HL7 International Clinical Interoperability Council. Package hl7.fhir.us.mcode#2.1.0 based on FHIR 4.0.1. Generated 2023-03-21
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change